Navidea Biopharmaceutical... (NAVB)
0.00
-0.00 (-100.00%)
At close: Feb 28, 2025, 3:00 PM
Navidea Biopharmaceuticals Forecast
Stock Price Forecast
The 0 analysts with 12-month price forecasts for NAVB stock have an median target of 0, with a low estimate of 0 and a high estimate of 0. The median target predicts a decrease of 0% from the current stock price of 0.00.
AI Analyst Report
According to 0 stock analyst, the rating for Navidea Biopharmaceuticals Inc. is "undefined". This means that the analyst believes this stock is likely to lead to similar returns than market as a whole.
Financial Forecast this Year
Revenue This Year
44.55M
from -
Increased by ∞B%
Revenue Next Year
112.47M
from 44.55M
Increased by 152.5%
EPS This Year
0.57
from null
Increased by ∞B%
EPS Next Year
2.36
from 0.57
Increased by 314.0%